Video summary

ГЗТ может лечить, а может вредить — всё решает дозировка

Main summary

Key takeaways

Wellness and Self-Improvement

Key points (HRT/testosterone dose & side effects)

The video argues that testosterone at ~250 mg/week can quickly create a “supraphysiological” state (higher than normal testosterone levels). This may trigger multiple side effects over roughly 1.5 years, even if some people assume this dose is “normal.”

When the dose might be “acceptable”

The speaker says 250 mg/week may be more plausible only in special scenarios, such as:

  • Very overweight individuals
  • People with very high SHBG, where testosterone binds strongly and free testosterone stays low

Reported side effects (and what’s driving them)

1) Rising red blood cell production + iron depletion (latent iron deficiency)

  • Testosterone can stimulate erythrocyte/“reticulocyte” production
  • This may cause falling iron stores (e.g., lower ferritin), even before hematocrit becomes clearly high
  • Progression can contribute to microcytosis (smaller RBCs with less hemoglobin)
  • Mentioned symptoms:
    • Shortness of breath
    • Higher pulse
    • Impaired iron-dependent cellular processes

Wellness/self-care strategy given

  • Avoid large testosterone doses
  • Target free testosterone around 0.6–0.7 nmol/L
  • Maintain ferritin ≥ 70
  • If iron stores are low:
    • Often easiest: temporarily use iron drops
    • Then: take chelated iron (or adjust dosing if absorption is poor)

2) Kidney function markers trending worse (creatinine, cystatin C)

  • Testosterone is described as not directly nephrotoxic
  • But higher dosing + likely increased training and higher protein intake may increase overall body load
  • Creatinine/cystatin C changes may suggest filtration stress

Strategy

  • Monitor creatinine and cystatin C
  • If worsening:
    • Stop/reduce protein load
    • Stop/reduce HRT
    • Stop/reduce training (at least temporarily)
  • Consider reducing testosterone dose toward physiological levels

3) Worsening lipid profile (cardiovascular risk)

  • Higher testosterone → higher LDL
  • Increase in Apolipoprotein B (ApoB)
  • The speaker connects this to atherosclerosis risk and plaque formation
  • Claim: estradiol does not normalize lipids sufficiently; testosterone level is the main driver

Diet + meds strategy mentioned

  • Reduce testosterone dose (not always sufficient alone)
  • Diet changes:
    • More unsaturated fatty acids
    • More fiber
    • Less saturated fatty acids
  • Supplements/medications discussed (names as given in subtitles):
    • “Istimip” (unclear exact product name)
    • Possibly statins
    • Alternative/stronger options:
      • inclisiran
      • bempedoic acid (spelled differently in subtitles)

4) Hormonal cascade: high total T → low SHBG → very high free T → high estradiol + prolactin

The video’s central mechanism:

  • High total testosterone lowers SHBG
  • Low SHBG → free testosterone becomes very high
  • That increases aromatization → very high estradiol
  • Prolactin may also rise

Potential downstream issues listed

  • Edema
  • Unstable mood/psycho-emotional state
  • Female-type fat distribution
  • Possible gynecomastia
  • High free T → excess DHT, potentially affecting:
    • Prostate issues
    • Oily skin
    • Hair loss
  • Elevated prolactin → decreased libido
  • Mention of “prophylactic gynecomastia” as a possible link (as stated)

Strategy

  • Avoid excessive testosterone dose
  • Consider that proper aromatase inhibitor dosing (anastrozole) could normalize:
    • Estradiol
    • Prolactin
  • The speaker suggests that reducing testosterone dose (even by ~half) could normalize estradiol/prolactin and reduce “more than half” of the problems (iron/lipids may not fully improve)

5) Thyroid dysfunction (indirect)

  • TSH can remain normal
  • T4 may decrease
  • Iodine appears low
  • Framed as potentially indirect (overall system stress)

Note

  • No specific thyroid-targeted intervention is described in detail, but monitoring is implied.

6) Counterpoint: insulin/glucose markers look fine

  • Insulin, glucose, and HbA1c are described as not problematic
  • The speaker claims testosterone deficiency contributes to insulin resistance, so high-dose testosterone may improve insulin sensitivity (in this case).

Overall conclusions / monitoring plan (explicitly suggested)

The speaker emphasizes more frequent testing and early reaction when using higher-than-physiological doses.

Recommended monitoring & actions

  • Injecting high doses requires closer monitoring
  • Test more often for:
    • Hormones (testosterone/estradiol and how anastrozole dosing changes outcomes)
    • Iron stores (e.g., ferritin)
    • Renal markers (creatinine, cystatin C)
    • Lipid profile (LDL, ApoB)
  • If issues appear:
    • Add iron supplements when ferritin is low
    • Add statins (or lipid-lowering meds) when lipids worsen
    • Adjust anastrozole to control estradiol (if needed)
    • In some cases mentioned: cabergoline (for prolactin-related concerns)

Key risk statement

  • Higher (non-physiological) doses → higher probability of multiple problems
  • Small doses may not require anastrozole, but higher T levels might

Presenters / sources

  • Anton Yuzhakov (presenter)

Original video